2 results match your criteria: "Huangkuang University[Affiliation]"
The Dose and Duration-dependent Association between Melatonin Treatment and Overall Cognition in Alzheimer's Dementia: A Network Meta- Analysis of Randomized Placebo-Controlled Trials.
Curr Neuropharmacol
September 2022
Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung, Taiwan.
Article Synopsis
- Alzheimer's dementia (AD) affects 3-32% of the population and currently has no effective treatments to slow cognitive decline, prompting investigation into exogenous melatonin as a potential therapy.
- A recent network meta-analysis compared the cognitive benefits of melatonin supplementation with FDA-approved medications, using changes in cognitive function (measured by the MMSE) and quality of life as key outcomes.
- Results show that medium-term low-dose melatonin leads to significant improvements in cognitive function and quality of life, with acceptability similar to that of placebo.
Special section on the Challenges in Environmental Science and Engineering, CESE-2014: 12-16 Oct., Persada Johor International Convention Centre, Johor Bahru, Malaysia.
Bioresour Technol
August 2015
Department of Safety, Health and Environmental Engineering, Huangkuang University, Taiwan. Electronic address: